NIH grants $5.4 million to advance the integration of genomics in learning health systems.

The National Institutes of Health (NIH) is providing $5.4 million in initial funding to launch a new program aimed at integrating genomics into learning health systems. These systems, found in many U.S. hospitals, link clinical care with research by continuously analyzing patient data to improve medical practices.

The Genomics-enabled Learning Health System (gLHS) Network is designed to explore ways to incorporate genomic data into existing learning health systems. As genomic testing becomes more prevalent, the growing availability of genomic data offers an opportunity to directly enhance patient care through these systems.

The gLHS Network comprises six clinical study sites and a coordinating center, each with an active learning health system. Each site will propose a project that utilizes patient data to refine some aspect of genomic medicine, such as genetic testing for hereditary conditions or tailoring medications based on a patient’s genomic information. The coordinating center will oversee project selection, focusing on initiatives that are feasible within the program’s five-year span and can be shared across the network.

“We are thrilled to unite this network to help translate genomic discoveries into clinical practice,” said Robb Rowley, M.D., program director in the Division of Genomic Medicine at NIH’s National Human Genome Research Institute (NHGRI). “uncover new medical insights from genomic data by Learning health systems offer”.

A key goal of the gLHS Network is to develop knowledge and practices that can be broadly applied to improve patient care beyond the participating sites. The coordinating center will also facilitate the sharing of tools and resources with the wider clinical and scientific communities, extending the network’s impact to under-resourced settings, such as rural hospitals or low-income areas.

“At present, learning health systems typically thrive in well-funded medical centers,” stated Teri Manolio, M.D., Ph.D., director of the Division of Genomic Medicine at NHGRI.. “We hope this initiative will create tools that enable limited-resource environments to enhance their use of genomic medicine.” 

The total funding for the program, provided by NHGRI and the National Cancer Institute (NCI), is $27 million over five years, contingent on available resources.

Must Read

Spinal Fusion Device Market to Surpass $11 Billion by 2033

Spinal fusion device market growth The worldwide Spinal fusion device...

Montana’s Healthcare Worker Shortage: Legislative Action to Fill the Gap.

Montana healthcare worker shortage, impacting hospitals, clinics, and long-term...

Beyond Medications: How Diet Aids Skin Health.

Medications control skin diseases, but diet is important as...

Sunita Williams and Butch Wilmore Return to Earth: The Health Challenges of Space Travel.

Effects of space travel on astronauts' health Because NASA...

The Future of Dermatology: How Telehealth is Revolutionizing Patient Care.

With the rise of teledermatology services, patients can now...

Topics

Beyond Medications: How Diet Aids Skin Health.

Medications control skin diseases, but diet is important as...

The Future of Dermatology: How Telehealth is Revolutionizing Patient Care.

With the rise of teledermatology services, patients can now...

Mounjaro: A New Breakthrough for Weight Loss in Non-Diabetic Individuals

Mounjaro for Weight Loss in Non-Diabetics Mounjaro for weight loss...

Johnson & Johnson MedTech Reveal Innovative Orthopaedic Breakthroughs at AAOS 2025.

At the American Academy of Orthopaedic Surgeons (AAOS) 2025...

The Emerging Risk of Fungal Infections: A Call for Immediate Action.

Fungal infections are becoming an escalating global health threat,...

Symplr’s Cloud-Based Platform: A Step Towards Smarter Healthcare Operations.

The healthcare sector is evolving every day, with technology...

Study Reveals Genetic Connection Between Obesity in People and Dogs.

Researchers have found a genetic connection between obesity in...

Sotyktu’s 5-Year Data Support Its Long-Term Efficacy for Plaque Psoriasis.

Five-year clinical results underscore the long-term efficacy and safety...

Related Articles

Popular Categories